NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









株式会社AiCELLEX

株式会社AiCELLEX

Private
HiroshimaHealthcare & Life Scienceshttps://aicellex.co.jp/

Last Round

Grant

Mar 25, 2024

Total Funding Raised

$7,000

Company Overview

株式会社AiCELLEX is a Japanese healthcare technology company that develops a cloud-based AI system, AiCELLEX, for managing and predicting the quality of cultured cells for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Drug Discovery, Biotechnology, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

cell culture quality controlAI image analysisregenerative medicinedrug discoveryautomated cell analysisquantitative cell analysispredictive cell analysislab automationcell therapy manufacturingcomputer visionlife sciences SaaSbiotech softwarein-process quality controlnon-destructive testinglife sciences consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

株式会社AiCELLEX Comps

Public and private peers based on sector, stage, and business model.

株式会社AiCELLEX comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

株式会社AiCELLEX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 25, 2024
AcceleratorAug 1, 2023

株式会社AiCELLEX Investors

Notable investors and investment history

株式会社AiCELLEX investors
InvestorRounds
Hiroshima Unicorn 10Accelerator
公益財団法人 YMFG地域企業助成基金Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2024

    $7K grant received from YMFG Regional Enterprise Support Fund.

  • Aug 1, 2023

    Received funding from Hiroshima Unicorn 10.

株式会社AiCELLEX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

株式会社AiCELLEX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 株式会社AiCELLEX's valuation, stock price, and market status.

Firmographic Details

HeadquartersHiroshima
Year Founded2017
Last FundingMar 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.